U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017


2022

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _________


Commission File No. 000-55114


CANFIELD MEDICAL SUPPLY,001-40471

SPLASH BEVERAGE GROUP, INC.

(NameExact name of registrant as specified in its charter)


ColoradoNevada 34-1720075
(State or other jurisdiction of
incorporation or formation)
 (I.R.S. employer
identification number)

4120 Boardman-Canfield Road, Canfield, Ohio 44406

1314 E Las Olas Blvd.Suite 221
Fort Lauderdale, FL33301
(Address of principal executive offices) (Zip code)

(Address of principal executive offices)

(330) 533-1914
954) 745-5815
(
Registrant'sRegistrant’s telephone number, including area code)

Not Applicable


(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.001 value per shareSBEVNYSE American LLC
Warrants to purchase one whole share of common stock at an exercise price of $4.60SBEV- WTNYSE American LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

¨ 

Yes No


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes  Yes    No


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See the definitions of "large“large accelerated filer," "accelerated filer"” “accelerated filer,” “smaller reporting company” and "smaller reporting company"“emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer
 
Accelerated filer
Non-accelerated filer
(Do not check if a smaller
Smaller reporting company)
company
Emerging growth company
Smaller reporting company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 Yes No


Indicate

Check whether the number of shares outstanding of eachregistrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the issuer's classesExchange Act after the distribution of common stock, as of the latest practicable date.securities under a plan confirmed by a court.  Yes  No

 As of November 6, 2017,14, 2022, there were 11,277,10040,101,116 shares of Common Stock issued and outstanding.


CANFIELD MEDICAL SUPPLY, INC.
FORM 10-Q

SPLASH BEVERAGE GROUP, INC.
FORM 10-Q
September 30, 2022

TABLE OF CONTENTS


PART I.  FINANCIAL INFORMATION Page
PART I: FINANCIAL INFORMATION
ITEM 1:FINANCIAL STATEMENTS1
 Condensed Consolidated Balance Sheets
Item 1.Financial Statements31
 Condensed Consolidated Statements of Operations2
 Condensed Balance Sheets (Unaudited)Consolidated Statement of Changes in Shareholders’ Equity3
 Condensed Consolidated Statements of Operations (Unaudited)Cash Flows4
 Notes to the Condensed Consolidated Financial Statements of Cash Flows (Unaudited)5
ITEM 2:  Notes to Condensed Financial Statements (Unaudited)MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS6-1018
ITEM 3:QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK20
Item 2.ITEM 4:Management's Discussion and Analysis of Financial Condition and Results of OperationsCONTROLS AND PROCEDURES1120
PART II: OTHER INFORMATION
Item 3.ITEM 1Quantitative and Qualitative Disclosures about Market RiskLEGAL PROCEEDINGS1322
ITEM 1A:RISK FACTORS22
Item 4.ITEM 2:Controls and ProceduresUNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS1322
ITEM 3:DEFAULTS UPON SENIOR SECURITIES22
PART II.  OTHER INFORMATIONITEM 4:MINE SAFETY DISCLOSURES1422
ITEM 5:OTHER INFORMATION22
Item 1.ITEM 6:Legal ProceedingsEXHIBITS1423
SIGNATURES24

Item 1A.Risk Factors14i
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds14
Item 3.Defaults Upon Senior Securities14
Item 4.Mine Safety Disclosures14
Item 5.Other Information14
Item 6.Exhibits14
Signatures15
 
2

PART I—I – FINANCIAL INFORMATION


Item

ITEM 1. Financial Statements.


CANFIELD MEDICAL SUPPLY, INC.
CONDENSED BALANCE SHEETS
(Unaudited)


  September 30,  December 31, 
ASSETS 2017  2016 
       
Current Assets      
Cash $37,281  $61,659 
Accounts receivable  231,010   206,254 
Inventory  29,037   25,231 
Total Current Assets  297,328   293,144 
         
Property and equipment, net of accumulated depreciation of $87,184 and $76,197
  56,155   62,190 
         
         
         Total Assets $353,483  $355,334 
         
LIABILITIES AND STOCKHOLDERS' EQUITY        
         
Current Liabilities        
Accounts payable and accrued liabilities $231,768  $209,069 
Line of credit  64,619   70,373 
Current portion of long-term debt  10,973   10,918 
Total Current Liabilities  307,360   290,360 
         
Long-term debt  17,096   25,305 
         
          Total Liabilities  324,456   315,665 
         
Stockholders' Equity        
Preferred stock, no par value; 5,000,000 shares authorized; no shares  -   - 
 issued and outstanding        
Common stock, no par value; 100,000,000 shares authorized;        
11,277,200 (September 30, 2017) and 10,927,200 (Dec. 31, 2016) shares     
 issued and outstanding  243,515   208,515 
Accumulated deficit  (214,488)  (168,846)
Total Stockholders' Equity  29,027   39,669 
Total Liabilities and Stockholders' Equity $353,483  $355,334 
         
FINANCIAL STATEMENTS

Splash Beverage Group, Inc.
Condensed Consolidated Balance Sheets
September 30, 2022 and December 31, 2021
(Unaudited)

         
Assets
  September 30, 2022 December 31, 2021
Current assets:        
Cash and cash equivalents $2,601,270  $4,181,383 
Accounts Receivable, net  1,478,613   1,114,452 
Prepaid Expenses  586,092   607,178 
Inventory, net  3,584,331   1,923,479 
Other receivables  461,353   41,939 
Assets from discontinued operations     473,461 
Total current assets  8,711,659   8,341,892 
         
Non-current assets:        
Deposit $49,251  $330,886 
Goodwill  256,823   256,823 
Other intangible assets, net  5,310,461   5,604,512 
Investment in Salt Tequila USA, LLC  250,000   250,000 
Right of use asset  828,066   1,031,472 
Property and equipment, net  556,936   569,785 
Total non-current assets  7,251,537   8,043,478 
Total assets $15,963,196  $16,385,370 
         
Liabilities and Stockholders’ Equity (Deficit)
         
Liabilities:        
Current liabilities        
Accounts payable and accrued expenses  2,088,180  $1,913,459 
Right of use liability - current  290,789   294,067 
Due to related parties  75,000     
Related party notes payable     653,081 
Notes payable, current portion  1,386,605   2,967,812 
Liability to issue shares  1,160,950     
Shareholder advances     390,500 
Accrued interest payable  183,553   171,452 
Liabilities from discontinued operations     389,086 
Total current liabilities  5,185,077   6,779,457 
         
Long-term Liabilities:        
Notes payable - noncurrent  248,428    
Right of use liability - noncurrent  537,447   732,686 
Total long-term liabilities  785,875   732,686 
Total liabilities  5,970,952   7,512,143 
         
Stockholders’ equity:        
Common Stock, $0.001 par, 150,000,000 shares authorized, 39,650,787 and 33,596,232 shares issued 39,650,787 and 33,596,232 outstanding, at September 30, 2022 and December 31, 2021,   respectively  39,651   33,596 
Additional paid in capital  117,487,992   99,480,188 
Accumulated Comprehensive Income - Translation  2,225    
Accumulated deficit  (107,537,624)  (90,640,557)
Total stockholders’ equity  9,992,244   8,873,227 
Total liabilities and stockholders’ equity $15,963,196  $16,385,370 

The accompanying footnotesnotes are an integral part of these unaudited condensed financial statements.

1
3

CANFIELD MEDICAL SUPPLY, INC.
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)

   Three months  Three months  Nine months  Nine months 
   ended  ended  ended  ended 
   
September 30,
2017
  
September 30,
2016
  
September 30,
2017
  
September 30,
2016
 
             
Sales (net of returns) $319,015  $236,059  $739,647  $695,697 
Cost of goods sold  148,664   113,572   343,034   348,686 
Gross profit  170,351   122,487   396,613   347,011 
                 
Operating expenses:                
Salaries and wages  80,347   75,649   241,891   214,787 
Professional Fees  4,851   6,054   36,751   24,378 
Depreciation  14,421   17,125   51,720   40,281 
Other selling, general and administrative  37,664   35,891   116,009   101,495 
    Total operating expenses  137,283   134,719   446,371   380,941 
                 
Income (loss) from operations  33,068   (12,232)  (49,758)  (33,930)
                 
Other income (expense):                
Interest expense  (1,186)  (1,258)  (3,660)  (3,156)
Gain on disposal of property and equipment  3,526   1,636   7,776   4,063 
   2,340   378   4,116   907 
                 
Income (loss) before provision for income taxes  35,408   (11,854)  (45,642)  (33,023)
Provision for income tax  -   -   -   - 
                 
Net income (loss) $35,408  $(11,854) $(45,642) $(33,023)
                 
Net income (loss) per share (basic and fully diluted) $0.00  $(0.00) $(0.00) $(0.00)
                 
Weighted average number of common shares outstanding  11,277,200   10,527,200   11,264,379   10,470,010 


Splash Beverage Group, Inc.
Condensed Consolidated Statements of Operations
For the Three and Nine Months Ended September 30, 2022 and September 30, 2021
(Unaudited)

                 
  Three months ended September 30, Nine months ended September 30,
  2022 2021 2022 2021
         
Gross sales $5,104,397  $2,950,187  $14,037,453  $8,573,945 
Customer discount  (233,990)  (122,794)  (741,532)  (319,867)
                 
Net revenues  4,870,407   2,827,393   13,295,921   8,254,078 
Cost of goods sold  (3,719,360)  (2,007,544)  (10,639,716)  (6,011,755)
Gross profit  1,151,047   819,849   2,656,205   2,242,323 
                 
Operating expenses:                
Contracted services  438,004   354,355   1,196,852   821,471 
Salary and wages  1,262,935   1,246,253   3,180,198   2,892,818 
Non-cash share based compensation  1,697,201   8,828,097   7,039,695   13,226,061 
Other general and administrative  2,116,824   2,214,274   5,945,023   7,767,241 
Sales and marketing  746,965   249,100   1,918,420   465,705 
Total operating expenses  6,261,929   12,892,079   19,280,188   25,173,296 
                 
Loss from continuing operations  (5,110,882)  (12,072,230)  (16,623,983)  (22,930,973)
                 
Other income/(expense):                
Other Income      3,632        3,632  
Interest income  158   527   2,867   642 
Interest expense  (66,193)  (100,128)  (225,543)  (341,715)
Gain from debt extinguishment     (1,695)     95,701 
Total other income/(expense)  (66,035)  (97,664)  (222,676)  (241,740)
                 
Provision for income taxes            
                 
Net loss from continuing operations, net of tax  (5,176,917)  (12,169,894)  

(16,846,659

)  (23,172,713)
                 
Net income (loss) from discontinued operations, net of tax     (22,077)  (199,154)  218,410 
Gain on sale of discontinued operations  33,116      148,747   —  
                 
Income (loss) from discontinued operations, net of tax  33,116   (22,077)  (50,407)  218,410 
                 
Net loss $

(5,143,801

) $(12,191,971) $(16,897,065) $(22,954,303)
                 
Loss per share - continuing operations                
Basic and dilutive $(0.14) $(0.40) $(0.46) $(0.83)
                 
Weighted average number of common shares outstanding - continuing operations                
Basic  37,364,031   30,515,251   36,417,222   27,512,776 
                 
Income(loss) per share - discontinued operations                
Basic $0.00  $0.00  $0.00  $0.01 
Dilutive $0.00  $0.00  $0.00  $0.01 
                 
Weighted average number of common shares outstanding - discontinued operations                
Basic  37,364,031   30,515,251   36,417,222   27,512,776 
Dilutive  38,861,544   30,515,251   36,417,222   30,809,267 

The accompanying footnotesnotes are an integral part of these unaudited condensed financial statements.

2

4

CANFIELD MEDICAL SUPPLY, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)

   Nine months ended  Nine months ended 
   September 30,  September 30, 
  2017  2016 
Cash Flows From Operating Activities:      
Net income (loss) $(45,642) $(33,023)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:     
Gain on disposal of property and equipment  (7,776)  (4,063)
Depreciation  51,720   40,281 
(Increase) decrease in accounts receivable  (24,756)  15,887 
(Increase) in inventory  (3,806)  (5,252)
Decrease in accounts payable and accrued liabilities  22,699   13,426 
     Net cash provided by (used for) operating activities  (7,561)  27,256 
         
Cash Flows From Investing Activities:        
Proceeds from sale of property and equipment  10,290   4,958 
Purchases of property and equipment  (48,199)  (43,194)
     Net cash (used for) investing activities  (37,909)  (38,236)
         
Cash Flows From Financing Activities:        
Net payments on line of credit  (5,754)  (5,448)
Payments on long-term debt  (8,154)  (6,173)
Proceeds from sales of common stock.  35,000   50,000 
       Net cash provided by financing activities  21,092   38,379 
         
Net Increase (Decrease) in Cash  (24,378)  27,399 
Cash At The Beginning Of The Period  61,659   7,343 
         
Cash At The End Of The Period $37,281  $34,742 
         
Schedule Of Non-Cash Investing And Financing Activities        
Purchase of equipment with long-term debt $-  $16,295 
         
Supplemental Disclosure        
Cash paid for interest $(3,660) $(3,156)
Cash paid for income taxes $-  $- 
         


Splash Beverage Group, Inc.
Condensed Consolidated Statements of Changes in Shareholders’ Equity
For the Three and Nine months ended September, 2022 and 2021
(Unaudited)

                             
              Total
  Common Stock Treasury Stock Additional Accumulated Stockholders'
  Shares Amount Shares Amount Paid-In Capital Deficit Equity (Deficit)
               
Balances at December 31, 2020  21,157,043   21,157         52,217,855   (61,589,735)  (9,350,724
                             
Issuance of warrants for services              1,186,596      1,186,596 
Issuance of common stock for services  168,333   168         730,867      731,035 
Issuance of common stock and warrants or cash  1,174,476   1,174         4,529,450      4,530,624 
Mezzanine shares  4,201,761   4,202         9,244,519      9,248,720 
Net loss                 (4,442,219)  (4,442,219)
                             
Balances at March 31, 2021  26,701,613   26,702   0  $  $67,909,286  $(66,031,954) $1,904,033 
                             
Issuance of warrants for services              1,186,596      1,186,596 
Issuance of common stock for services              1,369,918      1,369,918 
Issuance of common stock and warrants or cash  3,780,303   3,780         15,096,160      15,099,940 
Net loss                 (6,560,600)  (6,560,600)
                             
Balances at June 30, 2021  30,481,916   30,482   0  $  $85,561,961  $(72,592,554) $12,999,887 
                             
Issuance of warrants for services              3,010,012      3,010,012 
Issuance of common stock for services  2,136,819   2,137         6,109,774      6,111,911 
Net loss                 (12,169,894)  (12,169,894)
                             
Balances at September 30, 2021  32,618,735   32,619   0  $  $94,681,747  $(84,762,448)  9,951,916 

              Total
  Common Stock Treasury Stock Additional Accumulated Stockholders'
  Shares Amount Shares Amount Paid-In Capital Deficit Equity (Deficit)
               
Balances at December 31, 2021  33,596,232   33,596         99,480,188   (90,640,557)  8,873,227 
                             
Issuance of common stock on convertible instruments  223,596   224         1,206,287      1,206,511 
Issuance of warrants for services              1,242,697      1,242,697 
Issuance of common stock for services  550,000   550         1,112,845      1,113,395 
Issuance of common stock and warrants for cash  2,300,000   2,300         8,065,100      8,067,400 
Net loss                 (5,994,407)  (5,994,407 
                             
Balances at March 31, 2022  36,669,828   36,670         111,107,116   (96,634,964)  14,508,822 
                             
Issuance of warrants for services               1,174,289      1,174,289 
Issuance of common stock for services  500,000   500         1,429,500      1,430,000 
Issuance of common stock and warrants for cash  100,000   100         109,900      110,000 
Accumulated Comprehensive Income - Translation                      (6,570)  (6,570)
Net loss                   (5,758,857)  (5,758,857)
                             
Balances at June 30, 2022  37,269,828   37,270         113,820,805   (102,400,391)  11,457,684 
                      ��      
Issuance of warrants for services               1,036,066      1,036,066 
Issuance of common stock for APA  380,959   381         (381)     (0)
Issuance of common stock and warrants for cash  2,000,000   2,000         2,631,500      2,633,500 
Accumulated Comprehensive Income - Translation                      8,795   8,795 
Net loss                   (5,143,801)  (5,143,801)
                             
Balances at September 30, 2022  39,650,787   39,651         117,487,991   (107,535,397)  9,992,244 

The accompanying footnotesnotes are an integral part of these unaudited condensed consolidated financial statements.

3

Splash Beverage Group, Inc.
Condensed Consolidated Statement Cash Flows
For the Nine -Months Ended September 30, 2022 and 2021
(Unaudited)

         
  Nine months ended Nine months ended
  September 30, September 30,
  2022 2021
Net loss $(16,897,065) $(23,172,713)
Adjustments to reconcile net loss to net cash used in operating activities:                        
Depreciation and amortization  306,900   119,847 
ROU assets  203,406   86,699 
Gain from debt extinguishment     (95,701)
Gain from sale of discontinued operation  84,375     
Non-cash Share-based compensation  7,107,684   13,373,751 
Changes in working capital items:        
Accounts receivable, net  (364,161)  (716,370)
Inventory, net  (1,660,852)  (732,529)
Prepaid expenses and other current assets  (398,328)  (168,622)
Deposits  281,635    
Accounts payable and accrued expenses  698,170   (207,570)
Accrued Interest payable  12,101   (102,089)
Net cash used in operating activities - continuing operations  (10,626,135)  (11,615,297)
Net cash used in operating activities - discontinued operations     (218,410)
Cash Flows from Investing Activities:        
Capital Expenditures  (45,420)   
Net cash used in investing activities - continuing operations  (45,420)   
Net cash used in investing activities - discontinued operations  —     
Cash Flows from Financing Activities:        
Proceeds from issuance of Common stock  10,810,900   19,630,565 
Cash advance from shareholder  (280,500)  834,500 
Repayment of cash advance     (322,279)
Proceeds from issuance of debt  45,420   928,000 
Principal repayment of debt  (1,285,861)  (1,384,944)
ROU liability  (198,517)  (87,965)
Net cash provided by financing activities - continuing operations  9,091,442   19,597,877 
Net cash provided by financing activities - discontinued operations      
Net Change in Cash and Cash Equivalents  (1,580,113)  7,764,170 
Cash and Cash Equivalents, beginning of year  4,181,383   380,000 
         
Cash and Cash Equivalents, end of year $2,601,270  $8,144,171 
Supplemental Disclosure of Cash Flow Information:        
Cash paid for Interest $164,107  $173,363 
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Notes payable and accrued interest converted to common stock  (223,596 shares) $1,206,511  $ 
Liability issued for investment in SALT Tequila USA, LLC        

The accompanying notes are an integral part of these consolidated financial statements.

4
5

CANFIELD MEDICAL SUPPLY, INC.
CONDENSED NOTES TO FINANCIAL STATEMENTS
For

Splash Beverage Group, Inc.

Notes to the ThreeCondensed Consolidated Financial Statements

Note 1 – Business Organization and Nine Months Ended September 30, 2017Nature of Operations

Splash seeks to identify, acquire, and 2016 (Unaudited)


NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Canfieldbuild early stage or under-valued beverage brands that have strong growth potential within its distribution system. Splash’s distribution system is comprehensive in the US and is now expanding to select attractive international markets. The Splash brand portfolio is growing and diverse, covering multiple categories that are exhibiting strong growth in both the non-alcohol and alcohol sectors. Through its wholly owned subsidiary Qplash, Splash’s distribution reach includes e-commerce access to both B2B and B2C customers. Q-plash markets well known beverage brands to customers throughout the US that prefer delivery direct to their office, facilities and or homes.

On February 2021, Management initiated a plan to divest its Canfied Medical Supply, Inc. (the “Company”(“CMS”) business. As a result, the assets and operations of CMS have been retrospectively reflected as discontinued operations. On November 12, 2021 the Company changed its state of Domicile from Colorado to Nevada.

On June 30, 2022, the Company entered into a Business Transfer and Indemnity Agreement (“Agreement”). Pursuant to the Agreement, the Company transferred and assigned the assets and liabilities from the CMS business. Pursuant to the Agreement the Company was paid $31,000 and recorded a gain of $148,747 for the nine months ended September 30, 2022.

In coordination with uplisting to the NYSE on June 11, 2021, the Company consummated a 1.0 for 3.0 reverse stock split. All common stock shares stated herein have been adjusted on a retrospective basis to reflect the split.

Splash Beverage Group, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

These condensed consolidated financial statements include the accounts of Splash Beverage Group and its wholly owned subsidiaries, Splash International Holdings LLC, Splash Beverage Group Holding LLC, Splash Beverage Group II, Inc., was incorporatedCopa di Vino Wine Group, Inc. (“CdV”) and Splash Mexico SA de CV. CMS is reflected as discontinued operations until its disposal on June 30, 2022. All intercompany balances have been eliminated in consolidation.

Our accounting and reporting policies conform to accounting principles generally accepted in the StateUnited States of Ohio on September 3, 1992, and changed domicile to Colorado on April 18, 2012. The Company is in the business of home health services, primarily the selling of durable medical equipment and medical supplies to the public, nursing homes, hospitals, and other end users.


America (GAAP).

The accompanying condensed consolidated financial statements have been prepared by the Companyus without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the three and nine months ended September 30, 20172022 and 20162021 have been made.


Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of AmericaGAAP have been condensed or omitted.  It is suggested that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2016 audited financial statements. The results of operations for the periodsperiod ended September 30, 2017 and 20162022 are not necessarily indicative of the operating results for the full year.


Use of estimates


Estimates

The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principlesGAAP requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosuredisclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.


Cash Equivalents and cash equivalents


The Company considersConcentration of Cash Balance

We consider all highly liquid investmentssecurities with an original maturity of twelvethree months or less asto be cash equivalents.


Accounts receivable

The majority We had no cash equivalents at September 30, 2022 or December 31, 2021.

Our cash in bank deposit amounts, at times, may exceed federally insured limits of the Company’s revenues are received from Medicare, Medicaid, and private insurance companies.  As such, the Company records revenues at allowable amounts, net of estimated allowances and discounts based on contracted prices and historical collection rates.  The Company reviews accounts receivable periodically for collectability and establishes an allowance for doubtful accounts and records bad debt expense when deemed necessary.$250,000. At September 30, 20172022 we had $2,210,567 in excess of the federally insured limits. Our bank deposit amounts in Mexico of $1,940 are uninsured. At December 31, 2021 we had $3,643,474 over the federally insured limits. Our cash in uninsured foreign bank accounts was $10,749 at December 31, 2021.

Splash Beverage Group, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 2 – Summary of Significant Accounting Policies, continued

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are carried at their estimated recoverable amounts and are periodically evaluated for collectability based on past credit history with clients and other factors. We establish provisions for losses on accounts receivable on the basis of loss experience, known and inherent risk in the account balance, and current economic conditions. At September 30, 2022 and December 31, 2016,2021, our accounts receivable amounts are reflected net of allowances of $13,827 and $45,203, respectively.

Inventory

Inventory is stated at the Company has determined that no allowancelower of cost or net realizable value and accounted for doubtful accounts is necessary.


using the weighted average cost method. The inventory balances at September 30, 2022 and December 31, 2021 consisted of raw materials, work-in-process, and finished goods held for distribution. The cost elements of inventory consist of purchase of products, transportation, and warehousing. We establish provisions for excess or inventory near expiration are based on management’s estimates of forecast turnover of inventories on hand and under contract. A significant change in the timing or level of demand for certain products as compared to forecast amounts may result in recording additional provisions for excess or expired inventory in the future. Provisions for excess inventory are included in cost of goods sold and have historically been adequate to provide for losses on inventory. We manage inventory levels and purchase commitments in an effort to maximize utilization of inventory on hand and under commitments. The amount of our reserve was $67,170 and $223,223 at September 30, 2022 and December 31, 2021, respectively.

Property and equipment


PropertyEquipment

We record property and equipment are recorded at cost when purchased. Depreciation is recorded for property, equipment, and depreciated under straight line methodssoftware using the straight-line method over each item'sthe estimated economic useful life.


6

CANFIELD MEDICAL SUPPLY, INC.
CONDENSED NOTES TO FINANCIAL STATEMENTS
Forlives of assets, which range from 3-39 years. Company management reviews the Threerecoverability of all long-lived assets, including the related useful lives, whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset might not be recoverable. Furniture and Nine Months Endedcomputer equipment of $60,626 was no longer in use and written off as of September 30, 20172022.

Depreciation expense totaled $27,762 and 2016 (Unaudited)


NOTE 1.  ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued):

Inventory

The Company carries inventory of durable medical equipment and medical supplies for resale.  Inventory is accounted for on a first–in first-out basis.

Revenue recognition

The Company’s primary source of revenue is reimbursement from Medicare, Medicaid, and private insurance companies$44,465 for the sale of medical equipmentthree months ended September 30, 2022 and supplies to patients. Revenue from product sales is recognized subsequent to a patient (customer) ordering a product at an agreed-upon price,September 30, 2021, respectively. Depreciation expense totaled $101,991 and when delivery has occurred and collectability is reasonably assured. A purchase arrangement is evidenced by a written order, with delivery considered as made after physical customer acceptance. Although rare, defective products may be returned, with other return issues considered on a case-by-case basis. Services, such as periodic scheduled deliveries, are contracted in writing, and generally billed monthly. Any service revenue earned by the Company$80,048 for services, such as safety and set up consulting or claims processing, is recorded after the service is performed. Rental of durable home medical equipment is evidenced by written contract, with revenue recognized when rent is earned.

Advertising costs

Advertising costs are expensed as incurred. The Company had advertising costs during the nine months ended September 30, 20172022 and 2016September 30, 2021, respectively. Property and equipment as of $5,215September 30, 2022 and $4,149 respectively.

Income tax

December 31, 2021 consisted of the following:

Schedule of Property and equipment        
  September 30, 2022 December 31, 2021
Auto $45,420    
Machinery & Equipment $1,108,870   1,108,870 
Buildings $282,988   279,543 
Leasehold Improvements $699,512   662,537 
Office Furniture & Fixtures $13,635   70,960 
Property and equipment, at cost $2,150,425  $2,121,910 
Accumulated depreciation $(1,593,489)  (1,552,125)
Property and equipment, net $556,936   569,785 

Excise Taxes

The Company accountspays alcohol excise taxes based on product sales to both the Oregon Liquor Control Commission and to the U.S. Department of the Treasury, Alcohol and Tobacco Tax and Trade Bureau (TTB). The Company is liable for the taxes upon the removal of product from the Company’s warehouse on a per gallon basis. The federal tax rate is affected by a small winery tax credit provision which decreases based upon the number of gallons of wine production in a year rather than the quantity sold.

Splash Beverage Group, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 2 – Summary of Significant Accounting Policies, continued

Fair Value of Financial Instruments

Financial Accounting Standards (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows:

Level 1 -Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities.
Level 2 -Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active).
Level 3 -Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable.

The liabilities and indebtedness presented on the condensed consolidated financial statements approximate fair values at September 30, 2022 and December 31, 2021, consistent with recent negotiations of notes payable and due to the short duration of maturities and market rates of interest.

Splash Beverage Group, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 2 – Summary of Significant Accounting Policies, continued

Revenue Recognition

We recognize revenue under ASC 606, Revenue from Contracts with Customers (Topic 606). This guidance sets forth a five-step model which depicts the recognition of revenue in an amount that reflects what we expect to receive in exchange for the transfer of goods or services to customers.

We recognize revenue when our performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control of our products is transferred upon delivery to the customer. Revenue is measured as the amount of consideration that we expect to receive in exchange for transferring goods and is presented net of provisions for customer returns and allowances. The amount of consideration we receive and revenue we recognize varies with changes in customer incentives we offer to our customers and their customers. Sales taxes and other similar taxes are excluded from revenue.

Cost of Goods Sold

Cost of goods sold include the costs of products, packaging, transportation, warehousing, and costs associated with valuation allowances for expired, damaged or impaired inventory.

Distribution expenses to transport our finished goods, where applicable, and warehousing expense are accounted for within cost of goods.

Stock-Based Compensation

We account for stock-based compensation in accordance with ASC 718, ”Compensation - Stock Compensation”. Under the fair value recognition provisions, cost is measured at the grant date based on the fair value of the award and is recognized as expense ratably over the requisite service period, which is generally the award’s vesting period. We use the Black-Scholes option pricing model to determine the fair value of stock-based awards. We early adopted ASU 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting”, which aligns accounting treatment for such awards to non-employees with the existing guidance on employee share-based compensation in ASC 718.

Income Taxes

We use the liability method of accounting for income taxes pursuant toas set forth in ASC 740.740, ”Income Taxes”. Under ASC 740,the liability method, deferred taxes are provided for usingdetermined based on the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amountsfinancial statement and tax basis of assets and liabilities and theirusing tax bases. Deferred tax assets are reduced byrates expected to be in effect during the years in which the basis differences reverse. We record a valuation allowance when in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred

Company management assesses its income tax assetspositions and liabilitiesrecords tax benefits for all years subject to examination based upon its evaluation of the facts, circumstances and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, our policy is to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information.

For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements. Company management has determined that there are adjusted forno material uncertain tax positions at September 30, 2022 and December 31, 2021.

Splash Beverage Group, Inc.

Notes to the effectsCondensed Consolidated Financial Statements

Note 2 – Summary of changes in tax laws and rates on the date of enactment.


Significant Accounting Policies, continued

Net income (loss) per share


The net income (loss) per share is computed by dividing the net income (loss) by the weighted average number of shares of common stock outstanding. Warrants, stock options, and common stock issuable upon the conversion of the Company'sCompany’s convertible debt or preferred stock (if any), are not included in the computation if the effect would be anti-dilutive and would increaseanti-dilutive.

Advertising

We conduct advertising for the earnings or decrease loss per share.


There were no potentially dilutive debt or equity instruments issued or outstanding during the nine months ended September 30, 2017 or 2016.




7

CANFIELD MEDICAL SUPPLY, INC.
CONDENSED NOTES TO FINANCIAL STATEMENTS
For the Three and Nine Months Ended September 30, 2017 and 2016 (Unaudited)

NOTE 1.  ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued):

Financial instruments

The carrying valuepromotion of the Company’s financial instruments, as reported in the accompanying balance sheets, approximates fair value.

Concentrations

Financial instruments that potentially subject the Company to concentrations of credit risk include cash and cash equivalents.  The Company places its cash and cash equivalents at well-known financial institutions, where at times, such balances may exceed FDIC insurance limits.

The Company receives a significant amount of its revenues in reimbursements from Medicare and Medicaid through competitive bidding processes.  There is no guarantee that the Company will continue to be selected as a winning contract supplier under future bidding rounds.

Long-lived assets

our products. In accordance with ASC 350, the Company regularly reviews the carrying value720-35, advertising costs are charged to operations when incurred. We recorded advertising and marketing expense of intangible$746,965 and other long-lived assets$249,100 for the existence of facts or circumstances, both internally and externally, that suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-lived asset exceeds its fair value.

Products and services, geographic areas and major customers

The Company’s business of medical supply sales constitutes one operating segment. All revenues each year were domestic and to external customers.



8


CANFIELD MEDICAL SUPPLY, INC.
CONDENSED NOTES TO FINANCIAL STATEMENTS
For the Three and Nine Months Endedthree-months ended September 30, 20172022 and 2016 (Unaudited)

NOTE 2.  PROPERTY AND EQUIPMENT

Fixed assets are comprised2021, respectively. We recorded advertising and marketing expense of office equipment, vehicles,$1,918,420 and the wheelchair and hospital bed rental pool, which consists of wheelchairs and hospital beds rented to customers over the shorter of the 13-month rental period mandated by Medicaid and Medicare, or the period over which the customer requires use of the wheelchair or hospital bed.  At the end of the use period, the wheelchair or hospital bed is either returned to the pool to be rented to another customer, or title of the chair or bed is transferred to the customer.  Depreciation is computed over the estimated useful life of the assets, ranging from 13 months to 7 years, on the straight-line basis.  Depreciation expense$465,705 for the nine months ended September 30, 20172022 and 2016 was $51,7202021, respectively.

Goodwill and $40,281, respectively.  Accumulated depreciation totaled $87,184Intangibles Assets

Goodwill represents the excess of acquisition cost over the fair value of the net assets acquired and $76,197is not subject to amortization. The Company reviews goodwill annually in the fourth quarter for impairment or when circumstances indicate carrying value may exceed the fair value. This evaluation is performed at September 30, 2017the reporting unit level. If a qualitative assessment indicates that it is more likely than not that the fair value is less than carrying value, a quantitative analysis is completed using either the income or market approach, or a combination of both. The income approach estimates fair value based on expected discounted future cash flows, while the market approach uses comparable public companies and December 31, 2016, respectively.


NOTE 3.  LINE OF CREDIT

At September 30, 2017transactions to develop metrics to be applied to historical and December 31, 2016,expected future operating results.

Intangible assets consist of customer lists, brands and license agreements acquired in the acquisition of CdV. The Company owedamortizes intangible assets with finite lives on a bank $64,619straight-line basis over their estimated useful lives of 15 years.

Splash Beverage Group, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 2 – Summary of Significant Accounting Policies, continued

Long-lived assets

The Company evaluates long-lived assets for impairment on an annual basis when relocating or closing a facility, or when events or changes in circumstances may indicate the carrying amount of the asset group, generally an individual warehouse, may not be fully recoverable. For asset groups held and $70,373 respectively,used, including warehouses to be relocated, the carrying value of the asset group is considered recoverable when the estimated future undiscounted cash flows generated from the use and eventual disposition of the asset group exceed the respective carrying value. In the event that the carrying value is not considered recoverable, an impairment loss is recognized for the asset group to be held and used equal to the excess of the carrying value above the estimated fair value of the asset group. For asset groups classified as held-for-sale (disposal group), the carrying value is compared to the disposal group’s fair value less costs to sell. The Company estimates fair value by obtaining market appraisals from third party brokers or using other valuation techniques.

Recent Accounting Pronouncements

Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under a revolving line of credit. The line of credit isthe circumstances.

Reclassifications

Certain prior period amounts have been reclassified to conform with the current year presentation.

Splash Beverage Group, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 3 – Notes Payable and Related Party Notes Payable

Notes payable are generally nonrecourse and secured by all Company assets, is capped at $100,000, is due on demand, and bears interest at variable rates approximating 6% on average. owned assets.

             
  Interest Rate September 30, 2022 December 31, 2021
Notes Payable and Convertible Notes Payable      
In March 2014, we entered into a short-term loan agreement with an entity in the amount of $200,000. The note included warrants for 272,584 shares of common stock at $0.94 per share. The warrants expired unexercised on February 28, 2017. The loan matured and remains in default.  8%  200,000   200,000 
             
In September 2021, we entered into a twelve-month loan with a company in the amount of $208,000. The principal and interest was paid off in June 2022  4.8%     116,478 
             
In December 2020, we entered into a 56 month loan with a company in the amount of $1,578,237. The loan requires payments of 3.75% of the previous months revenue. Note is due September 2025  17%  1,162,320   1,423,334 
             
In April 2021, we entered into a six-month convertible loan with an individual in the amount of $84,000. The loan had an original maturity of October 2021 with principal and interest due at maturity. The loan was extended to January 2023.  7%  84,000   84,000 
             
In April 2021, we entered into a six-month convertible loan with an individual in the amount of $84,000. The loan had an original maturity of October 2021 with principal and interest due at maturity. The loan was extended to January 2023  7%  84,000   84,000 
             
In May 2021, we entered into a six-month convertible loan with an individual in the amount of $50,000. The loan had an original maturity of October 2021 with principal and interest due at maturity. The loan was extended to January 2023.  7%  50,000   50,000 
             
In May 2021, we entered into a six-month convertible loan with an individual in the amount of $500,000. The loan had an original maturity of October 2021 with principal and interest due at maturity. The principal and interest was converted into shares of common stock in February 2022.  7%     500,000 
             
In May 2021, we entered into a six-month convertible loan with an individual in the amount of $10,000. The loan had an original maturity of October 2021 with principal and interest due at maturity. The loan was extended to January 2023  7%  10,000   10,000 
             
In May 2021, we entered into a six-month convertible loan with an individual in the amount of $200,000. The loan had an original maturity of October 2021 with principal and interest due at maturity. The principal and interest was converted into shares of common stock in February 2022.  7%     200,000 
             
In November 2021, we entered into a one-year convertible loan with an individual in the amount of $300,000. The principal and interest was converted to shares of common stock in April 2022.  7%     300,000 
             
 In August 2022, we entered into an 56-month auto loan in the amount of $45,420.  2.35 %  44,713    —  
             
   Total notes payable
and convertible notes payable
  $1,635,033  $2,967,812 
             
   Less current portion   (1,386,605)  (2,967,812)
             
   Long-term notes payable
and convertible notes payable
  $248,428  $ 

Interest expense underon notes payable was $65,007 and $82,871 for the note approximated $3,336three months ended September 30, 2022 and $2,250 during each of2021, respectively.

Interest expense on notes payable was $217,123 and $340,653 for the nine months ended September 30, 20172022 and 2016,2021 respectively. DuringAccrued interest was $183,553 at September 30, 2022. 

Splash Beverage Group, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 3– Notes Payable and Related Party Notes Payable

Schedule of related party notes payable            
  Interest Rate September 30, 2022 December 31, 2021
Related Parties Notes Payable         
          
In December 2020, we entered into an 18 month loan with an individual in the amount of $2,000,000. The loan was paid off in June 2022.  2.0%     653,081 
             
   Less current portion      (653,081)
             
   Long-term notes payable  $  $ 

Interest expense on related party notes payable was $0 and $5,995 for the three months ended September 30, 2022 and 2021, respectively. Interest expense on related party notes payable was $5,407 and $21,833 for the nine months ended September 30, 20172022 and 2016,2021, respectively. Accrued interest was $0 as of September 30, 2022.

Splash Beverage Group, Inc.

Notes to the Company made principalCondensed Consolidated Financial Statements

Note 4 – Licensing Agreement and Royalty Payable

We have a licensing agreement with ABG TapouT, LLC (“TapouT”), providing us with licensing rights to the brand “TapouT” on energy drinks, energy shots, water, teas and sports drinks for beverages sold in the United States of America, its territories, possessions, U.S. military bases and Mexico. Under the terms of the agreement, we are required to pay a 6% royalty on net sales, as defined. We are required to make minimum royalty monthly payments of $5,754$54,450 in 2022 and $5,448, respectively.


NOTE 4.  LONG-TERM DEBT

Long-term debt consists of the following:

  
September 30,
2017
  
December 31,
2016
 
       
3.53% installment note payable $352 monthly,  including    interest, through July 2019, collateralized by vehicle with carrying value of $4,078 $7,496  $10,426 
3.79% installment note payable $299 monthly, including        
interest, through July 2021, collateralized by vehicle with carrying value of $12,466  12,764   15,052 
         
2.99% installment note payable $350 monthly, including    interest, through August 2019, collateralized by vehicle with carrying value of $6,806  7,809   10,745 
   28,069   36,223 
Less principal due within one year  (10,973)  (10,918)
         
     TOTAL LONG-TERM DEBT $17,096  $25,305 



9


CANFIELD MEDICAL SUPPLY, INC.
CONDENSED NOTES TO FINANCIAL STATEMENTS
For the Three and Nine Months Ended$49,500 in 2021.

There were no unpaid royalties at September 30, 20172022. Royalty payments including the minimum totaling $490,050 and 2016 (Unaudited)


NOTE 5.  COMMON STOCK

$445,500 were made for the nine months ended September 30, 2022 and 2021, respectively, these costs are included in general and administrative expenses.

In connection with the Copa APA, we acquired the license to certain patents from 1/4 Vin SARL (“1/4 Vin”) On January February 16, 2018, the CdV entered into three separate license agreements with 1/4 Vin SARL, (1/4 Vin). 1/4 Vin has the right to license certain patents and patent applications relating to inventions, systems, and methods used in our manufacturing process. In exchange for notes payable, 1/4 Vin granted us a nonexclusive, royalty-bearing, non-assignable, nontransferable, terminable license which would continue until the subject equipment is no longer in service or the patents expire. Amortization is approximately $31,000 annually until the license agreement is fully amortized. The asset is being amortized over a 10 2017-year useful life.

Note 5– Stockholders’ Equity

Common Stock

During the three-months ended September 30, 2022, the Company issued 350,0002,000,000 shares of common stock as part of the public offering and 380,959 shares in settlement of litigation.

During the nine-months ended September 30, 2022, the Company issued 4,300,000 shares of common stock as part of the public offerings, 1,050,000 shares in exchange for services, 380,959 shares in settlement of litigation, 223,596 shares on convertible instruments, and 100,000 shares for cash.

Private Placement Memorandum (PPM)

In January 2021, the Board of Directors approved a Private Placement Memorandum (PPM) offering of 1,212,121 shares of the common stock of the Company, $0.001 value per share at a purchase price of $3.30 per share for aggregate gross proceeds of $4,000,000. As part of the PPM, each purchaser received a warrant to purchase one share for every two shares purchased. In February 2021, the Company issued a total of 1,212,355 shares and 606,178 warrants and received the gross proceeds of approximately $4,000,000.

Splash Beverage Group, Inc.

Notes to the Consolidated Financial Statements

Note 6 – Related Parties

There is a $75,000 balance due to a related party as of September 30, 2022 and $653,081 was outstanding as of December 31, 2021. 

Note 7 – Investment in Salt Tequila USA, LLC

We have a marketing and distribution agreement with SALT Tequila USA, LLC (“SALT”) for the manufacturing of our Tequila product line in Mexico.

We have a 22.5% percentage ownership interest in SALT and have the right to increase our ownership to 37.5%. This investment is accounted for at cost, due to our inability to exercise significant influence over the assets and operations.

Splash Beverage Group, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 8 – Operating Lease Obligations

Effective July 2018, we entered into a lease agreement for the right to use and occupy office space. The lease term commenced July 1, 2018 and is scheduled to expire after 36 months, on June 30, 2021. In July 2021, we executed a two-year renewal at the same monthly amount. A three-year lease was signed in September 2022.

Effective November 2019, we entered into a new lease with Interport Logistics, LLC. The lease term commenced on November 11, 2019 and is scheduled to expire on November 11, 2022, at which point it became month-to-month.

Effective May 2019, we entered into a new lease in Mexico. The lease commenced May 1, 2019 and was renewed on April 1, 2022 for one year.

Effective January 2021, we entered into a lease agreement for the right to use and occupy office space. The lease term commenced January 18, 2021 and was extended for 1 18 months to July 31, 2023.

Effective January 2021, we entered into a lease agreement for the right to use and occupy office and manufacturing space. The lease term commenced January 1, 2021 and is scheduled to expire after 60 months, on December 31, 2025.

The following table presents the discounted present value of minimum lease payments for our office and warehouses to the amounts reported as financial lease liabilities on the condensed consolidated balance sheet at September 30, 2022:

     
Undiscounted Future Minimum Lease Payments  Operating Lease  
2022 (three months)  93,643 
2023  293,050 
2024  252,000 
2025  252,000 
Total  890,693 
Amount representing imputed interest  (62,457)
Total Operating Lease Liability  828,236 
Current portion operating lease liability  290,789 
Operating lease liability, non-current  537,447 

The table below presents information for lease costs related to our operating leases at September 30, 2022

Schedule of lease costs
 Operating lease cost:
Amortization of leased assets543,865
Interest of lease liabilities93,630
 Total operating lease cost637,495

The table below presents lease-related terms and discount rates at September 30, 2022

Summary of lease-related terms and discount rates
Summary of lease-related terms and discount rates
Remaining term on leases1 to 39 months
Incremented borrowing rate5.0%

Splash Beverage Group, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 9 – Segment Reporting

The Company evaluates segment reporting in accordance with the FASB Accounting Standards Codification Topic 280, Segment Reporting, each reporting period, including evaluating the reporting package reviewed by the Chief Executive Officer and Chief Financial Officer.

The CdV business is included in our Splash Beverage Group segment.

Schedule of Segment Reporting Information                
  Three-Months Ended Nine-Months Ended
Net revenue Q3 2022 Q3 2021 Q3 2022 Q3 2021
Splash Beverage Group  1,147,249   960,381   3,980,795   3,351,990 
E-Commerce  3,723,158   1,867,012   9,315,126   4,902,088 
                 
Total net revenues continuing operations  4,870,407   2,827,393   13,295,921   8,254,078 
                 
Total net revenues discontinued operations  0   207,043   385,174   855,262 

Total assets 

September 30,

2022
 

December 31,

2021
Splash Beverage Group  14,206,415   14,998,597 
E-Commerce  1,756,781   913,312 
Medical Devices - Discontinued     473,461 
         
Total Assets  15,963,196   16,385,370 

Note 10 – Liability to Issue Shares

The Company has obligations to issue shares of its common stock at $.10 per share for total proceeds of $35,000 to unaffiliated individuals.


NOTE 6.  LEASE COMMITMENTS

The Company rents office space under a non-cancellable lease through September 2020 with monthly payments of approximately $2,292 plus costs.

Lease expense incurred for each of the nine months ended September 30, 20172022 arising from the following transactions:

·154,200 shares in connection with the conversion of indebtedness in the amount of $308,400
·Shares equal to $150,000 in connection with consulting services provided
·250,000 shares in connection with consulting services provided
·5,000 shares in connection with consulting services provided
·10,000 shares in connection with consulting services provided

Note 11 – Commitment and 2016 was approximately $20,620. Contingencies

We are a party to asserted claims and are subject to regulatory actions in the ordinary course of business. The results of such proceedings cannot be predicted with certainty, but we do not anticipate that the outcome, if any, arising out of any such matter will have a material adverse effect on its business, financial condition or results of operations.

Note 12– Subsequent Events

Subsequent to September 30, 2017, future minimum payments under2022 the leases total approximately $75,625 including:  2017 (balance) $6,875, 2018 - $27,500, 2019 - $27,500,Company’s Board approved the issuance of 225,000 shares associated with a 3 year contract and 2020 - $13,750.


NOTE 7.  GOING CONCERN

18,519 shares for services. The Company has suffered losses from operations and has working capital and stockholders’ equity deficits. In all likelihood,issued 296,129 shares upon exercise of the Company will be required to make significant future expenditures in connectionunderwriters’ over-allotment that generated gross amount of $459,000. We have extended a licensing agreement with marketing efforts along with general administrative expenses. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

The Company may raise additional capitalABG TapouT, LLC (“TapouT”) through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan of selling medical supplies on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern.

NOTE 8.  SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the date these financial statements were available to be issued and determined that there are no reportable subsequent events.


10

2028.

Item

ITEM 2. Management's DiscussionMANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Statement Regarding Forward-Looking Statements

The information in this discussion may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and AnalysisSection 21E of Financial Conditionthe Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and Resultsuncertainties, including statements regarding our capital needs, business strategy and expectations. Any statements that are not of Operations.


historical fact may be deemed to be forward-looking statements. These forward-looking statements involve substantial risks and uncertainties. In some cases you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue”, the negative of the terms or other comparable terminology. Actual events or results may differ materially from the anticipated results or other expectations expressed in the forward-looking statements. In evaluating these statements, you should consider various factors, including the risks included from time to time in other reports or registration statements filed with the United States Securities and Exchange Commission. These factors may cause our actual results to differ materially from any forward-looking statements. We disclaim any obligation to publicly update these statements or disclose any difference between actual results and those reflected in these statements.

Unless the context otherwise requires, references in this Form 10-Q to “we,” “us,” “our,” or the “Company” refer to Splash Beverage Group and its subsidiaries.

The following discussion and analysis should be read in conjunction with the Condensed Financial Statements (unaudited) and Notes to Condensed Financial Statements (unaudited) filed herein.


BUSINESS OVERVIEW

We primarily provide servicesherewith.

Business Overview

Splash seeks to identify, acquire, and build early stage or under-valued beverage brands that have strong growth potential within its distribution system. Splash’s distribution system is comprehensive in the US and is now expanding to select attractive international markets. The Splash brand portfolio is growing and diverse, covering multiple categories that are exhibiting strong growth in both the non-alcohol and alcohol sectors. Through its wholly owned subsidiary Qplash, Splash’s distribution reach includes e-commerce access to both B2B and B2C customers. Q-plash markets well known beverage brands to customers throughout the US that prefer delivery direct to their office, facilities and or homes.

Splash was originally incorporated in the State of Nevada under the name TapouT Beverages, Inc. for the purpose of acquiring the rights under a license agreement with TapouT, LLC (Authentic Brands Group) for the right to use the TapouT brand in connection with manufacturing and selling certain beverages.

On March 31, 2020, a wholly-owned subsidiary of a public entity called Canfield Medical Supply, Inc. (“CMS”) merged with and into Splash and Splash became a wholly-owned subsidiary of CMS. At the time of the merger CMS’s state of incorporation was Colorado.  At the time of the merger CMS’s common stock was quoted on the OTCQB.

On July 31, 2020, we changed our name from Canfield Medical Supply, Inc. to Splash Beverage Group, Inc.

On June 11, 2021, our common stock and warrants to purchase common stock began trading on the NYSE American under the symbols “SBEV” and SBEV WS,” respectively

On November 8, 2021, we changed our state of incorporation from Colorado to Nevada.

On June 30, 2022, Management completed its plan to divest its CMS’s business.

In coordination with uplisting to the rehabilitation market, which consists primarilyNYSE American on June 11, 2021 the Company consummated a 1.0 for 3.0 reverse stock split.

Results of home medical equipment and supplies.  More than 50% of our revenues are derived from the sale and rental of durable home medical equipment including such items as wheeled walkers, manual and power wheelchairs, hospital beds, ramps, bedside commodes, and miscellaneous bathroom equipment.  The balance of our revenue is from the sale of various home medical supplies including diabetic testing, incontinence, ostomy, wound care, and catheter care.  Our emphasis is on helping patients with mobility related limitations, but our overall business is aimed at helping patients remain in their homes instead of having to go to hospitals, rehab centers and other similar facilities.  Most of the equipment and supplies that we sell are prescribed by a physician as part of an overall care plan.


RESULTS OF OPERATION FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2017 AS COMPARED TO THE THREE MONTHS ENDED SEPTEMBER 30, 2016.

RevenuesOperations for the Three and Nine Months Ended September 30, 2022 compared to Three and Nine Months Ended September 30, 2021.

Net Revenue

Net revenues for the three and nine months ended September 30, 20172022 were $319,015 ashigher compared to the revenues of $236,059 for the three and nine months ended September 30, 2016.  The 35% increase in sales is2021 due to an increasing trend in powerchair sales.


increase from our vertically integrated B2B and B2C e-commerce distribution platform called Qplash (Qplash sells goods on both Amazon and Shopify), a number of retail chain authorizations has led to increased distribution on the beverage portfolio and a price increase on CdV.

Cost of Goods Sold

Cost of goods sold for the three and nine months ended September 30, 20172022 were $148,664 ashigher compared to cost of goods sold for the three and nine months ended September 30, 2016 of $113,572.2021. The 31% increase in the latest three monthscost of goods sold is primarily due to higher sales at Qplash, incremental volumes in the 35% increase in sales.


beverage portfolio and higher supply chain costs on both ingredients and freight.

Operating Expenses

Operating expenses for the three months ended September 30, 20172022 were $137,283 aslower compared to $134,719 for the three months ended September 30, 2016.  The 2% increase in operating expenses was primarily2021 due to the 6% increase in salaries and wages which was offset in part by small decreases in professional fees and depreciation.


The net income for the three months ended September 30, 2017 was $35,408 as compared to a net loss of $11,854 for the three months ended September 30, 2016.  The reasons for the $47,262 improvement include the fact that the sales increased by $82,956 while the cost of good sold only increased by $35,092.
11

RESULTS OF OPERATION FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2017 AS COMPARED TO THE NINE MONTHS ENDED SEPTEMBER 30, 2016.

Revenues for the nine months ended September 30, 2017 were $739,647 as compared to the revenues of $695,697 for the nine months ended September 30, 2016.  The 6% increase in sales is primarily due to an increasing trend in power chair sales.

Cost of goods sold for the nine months ended September 30, 2017 were $343,034 as compared to cost of goods sold for the nine months ended September 30, 2016 of $348,686.  The 2% decrease in the latest nine month period was due to the net effect of a decrease in cost of enteral nutrition products and increaseshare based compensation partially offset by increases in the purchase of high-price items such as power chairs, scooters, power vehicle lifts, and manual lifts.

marketing expenses. Operating expenses for the nine months ended September 30, 20172022 were $446,371 ashigher compared to $380,941 for the nine months ended September 30, 2016.  2021 driven by an increase in sales and marketing cost partially offset by lower non-cash compensation for services cost. In September 2021 we granted 1,065,000 options to purchase common stock of the Company to employees, consultants, and directors. These options vest over three years.

Interest Expense

Interest expenses for the three and nine months ended September 30, 2022 were lower compared to the three and nine months ended September 30, 2021 due to the paydown of notes payable.

Net Loss

The 17% increasenet loss for the three months ended September 30, 2022 was lower compared to the three months ended September 30, 2021. The decrease in the net loss is due to the $27,104our lower operating expenses and an increase in salaries and wages attributable to pay raises and the hiring of a sales representative during the third quarter of 2016, the $12,373 increase in professional fees incurred during the latest nine months for the audit of our December 31, 2016 financial statements and Form 10-K filing (we did not commence our December 31, 2015 audit until the second quarter of 2016), and the $14,514 increase in other general and administrative expenses comprised primarily of our new website development and outsourcing of our billing collections.


revenues. The net loss for the nine months ended September 30, 20172022 was $45,642 aslower compared to a net loss of $33,023 for the nine months ended September 30, 2016.2021. The reason for the increased lossdecrease in the first nine months of 2017 was primarily the $65,430net loss is due to our increase in e-commerce revenue and lower operating expenses discussed above.

expenses.

LIQUIDITY AND CAPITAL RESOURCES


Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

As of September 30, 2017,2022, we had negative working capitaltotal cash and cash equivalents of ($10,032)$2,601,270 as compared to working capital of $2,784 as ofwith $4,181,383 at December 31, 2016.


2021.

Net cash (used for)used for operating activities during the nine months ended September 30, 20172022 was ($7,561)$10,626,135 as compared to the net cash providedused by operating activities infor the nine months ended September 30, 20162021 of $27,256.$11,615,297. The primary reasonreasons for the change in net cash used for operating activities wasis due to losses sustained, increases in inventory and costs incurred in connection with the increase in the net loss from $33,023 incompany’s shelf registration statement on Form S-3.

For the nine months ended September 30, 20162022, an SUV was purchased and financed with a loan. We did not use or receive cash relating to a net loss of $45,642 in the latest nine-month period as explained previously. 

Net cash used for investing activities during the nine months ended September 30, 2017 was $37,909 which included $48,199 used for the purchase of equipment.  In comparison, during the nine months ended September 30, 2016, the Company used $43,194 for the purchase of equipment.

30,2021

Net cash provided by financing activities during the nine months ended September 30, 20172022 was $21,092 as$9,091,442 compared to $38,379$19,597,565 provided byfrom financing activities infor the nine months ended September 30, 2016.  The Company sold shares of its common stock during2021. During the nine months ended September 30, 20172022, we received $12,300,000 from investors from the Company Shelf Registration Statement on Form S-3, which was offset by repayments to debt holders of $1,285,861 and 2016 to raise $35,000 and $50,000, respectively, to help payfinancing fees associated with the Shelf Registration Statement $1,738,896.

Inventory increased for the costs associated with being a public company.  Minimal payments towards the Company’s line of credit and notes payable were also made during each of the nine-month periodsthree months ended September 30, 2017 and 2016.

12

in preparation to fulfil orders related to new retail chain authorizations.

CONTRACTUAL OBLIGATIONS


Minimum Royalty Payments:

We have a licensing agreement with ABG TapouT, LLC (“TapouT”). Under the licensing agreement, we have minimum royalty payments to TapouT for $653,400 in 2022.

Inventory Purchase Commitments:

None.


OFF-BALANCE SHEET ARRANGEMENTS

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements (as that term is defined in Item 303 of Regulation S-K) that are reasonably likely to have a current or future material effect on our financial condition, revenue or expenses, results of operations, liquidity, and capital expenditures or capital resources.


Item

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk. 


QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.


required for Smaller Reporting Companies.

Item

ITEM 4. CONTROLS AND PROCEDURES

(a)Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and Procedures.


(a)  Evaluationprocedures that are designed to ensure that information required to be disclosed in our Securities and Exchange Commission Act of Disclosure Controls1934 reports is recorded, processed, summarized, and Procedures.

Our Chief Executive Officerreported within the time periods specified in the Securities and Principal Financial Officer have evaluatedExchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As further discussed below, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operationsoperation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the end of the period covered by this quarterly report,Exchange Act. Based on that evaluation, our chief executive officer and havechief financial officer concluded that, our disclosure controls and procedures are adequate.


(b)  Changes in Internal Control over Financial Reporting.

No changebecause of certain material weaknesses in our internal control over financial reporting, (asour disclosure controls and procedures as defined in Rules 13a-15(f)Rule 13a-15(e) and 15d-15(f)15d-15(e) under the Exchange Act) occurred duringAct were not effective as of September 30, 2022.

We hired a consultant to advise on technical issues related to U.S. generally accepted accounting principles as relates to the period covered by this report that has materially affected,maintenance of our accounting books and records and the preparation of our consolidated financial statements. Although we are aware of the risks associated with not having dedicated accounting personnel, we are also at an early stage in the development of our business. We anticipate expanding our accounting functions with dedicated staff and improving our internal accounting procedures and separation of duties when we can absorb the costs of such expansion and improvement with additional capital resources. In the meantime, management will continue to observe and assess our internal accounting function and make necessary improvements whenever they may be required. If our remedial measures are insufficient to address the material weakness, or is reasonably likely to materially affect,if additional material weaknesses or significant deficiencies in our internal control over financial reporting are discovered or occur in the future, our consolidated financial statements may contain material misstatements, and we could be required to restate our financial results. In addition, if we are unable to successfully remediate this material weakness and if we are unable to produce accurate and timely financial statements, our stock price may be adversely affected and we may be unable to maintain compliance with applicable stock exchange listing requirements.

(b)Changes in Internal Controls over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting.



13

Our internal control over financial reporting is a process designed to provide reasonable, but not absolute, assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

Our management assessed the effectiveness of the Company’s internal control over financial reporting at September 30, 2022, and this assessment identified some deficiencies in our internal control over financial reporting.

Remediation plan

The company has established two procedures to begin addressing the controls area. Each quarter Senior Managers respond to a questionnaire to identify areas that would impact the company’s financial statements to be reviewed against the reported financial statements. Also, quarterly financial packages are collected and reviewed with each subsidiary to analyze and ensure completeness of their financial statements.

Actions have been taken regarding the remediation plan, however there remain actions to complete:

Walk through and document critical process. This portion of the plan will commence in Q3
Review resources and organizational structure to address segregation of duty issues and support the
 jobs assigned. The structure has been defined and resources are being identified.
Implement a BI tool that will replace Excel worksheets that can be prone to errors. The tool has been selected and implementation is taking place.

PART II – OTHER INFORMATION


Item

ITEM 1. Legal Proceedings.


None.

LEGAL PROCEEDINGS.

On June 10, 2022, Copa Di Vino Corporation (“Copa”) filed a lawsuit against the Company in Broward County, Florida. The complaint alleged that the Company still owed part of the final payment under the December 24, 2020 Asset Purchase Agreement (“APA”) between Copa and the Company. The Company settled the lawsuit with Copa Di Vino Corporation. This matter was settled in September 2022 without the admission of liability or wrongdoing on the part of Splash.  In exchange for full release from COPA, the Company agreed to issue 380,959 shares of the Company’s common stock. The Company entered into the settlement solely to avoid the costs and uncertainty of litigation.

Item

ITEM 1A. Risk Factors.


Not applicable.

RISK FACTORS

No new risk factors noted since our Annual Report on Form 10-K for the year ended December 31, 2021.

Item

ITEM 2. Unregistered SalesUNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the three months ended March 31, 2022, we issued 550,000 shares of Equity Securitiescommon stock in exchange for services, 2,300,000 shares pursuant to our public offering to increase working capital, and Use223,596 shares were issued on convertible instruments. For the three-month-ended June 30, 2022 we issued 500,000 shares in exchange for service provided that were valued at a fair market value stock price based on the agreement date and 100,000 shares for cash. During the three-months ended September 30, 2022 we issued 2,000,000 shares pursuant to our public offering to support inventory increases. The Company also issued 380,959 shares in settlement of Proceeds.


None.

litigation. We recognized share-based compensation and warrant expense for the nine-months ended September 30, 2022 of $6,717,504 which is classified within non-cash compensation on our Condensed Consolidated Statements of Operations.

Item

ITEM 3. Defaults Upon Senior Securities.


DEFAULTS UPON SENIOR SECURITIES

None.


Item

ITEM 4. Mine Safety Disclosures.


Not applicable.

MINE SAFETY DISCLOSURES

No disclosure required.

Item

ITEM 5. Other Information.


OTHER INFORMATION

None.


Item

ITEM 6. Exhibits.


EXHIBITS

(a) Exhibits required by Item 601 of Regulation S-K.


ExhibitsDescription





101XBRL Exhibits


14

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 CANFIELD MEDICAL SUPPLY,SPLASH BEVERAE GROUP, INC.
   
Date: November 13, 201714, 2022By:/s/ Michael J. WestRobert Nistico
  
Michael J. West, PresidentRobert Nistico, Chairman and CEO
(Principal Executive Officer)
  (principal executive officer)

Date: November 14, 2022By:/s/ Ron Wall
  
Date:  November 13, 2017By:/s/ Stephen H. WestRon Wall, CFO
  
Stephen H. West, CFO
(Principal Financial Officerprincipal accounting officer and Principal Accounting Officer)
principal financial officer) 

24




15